Found: 10
Select item for more details and to access through your institution.
The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 2, p. 251, doi. 10.1093/ejendo/lvae091
- By:
- Publication type:
- Article
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 5, p. 685, doi. 10.1530/EJE-22-0647
- By:
- Publication type:
- Article
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01523-y
- By:
- Publication type:
- Article
Adult brainstem glioma differential diagnoses: an MRI-based approach in a series of 68 patients.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 8, p. 4349, doi. 10.1007/s00415-022-11070-6
- By:
- Publication type:
- Article
T2‐Fluid‐attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 9, p. 2879, doi. 10.1111/ene.15873
- By:
- Publication type:
- Article
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 1, p. 83, doi. 10.1007/s00401-022-02512-6
- By:
- Publication type:
- Article
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 151, doi. 10.1007/s11060-022-04052-1
- By:
- Publication type:
- Article
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 825, doi. 10.1093/oncolo/oyad095
- By:
- Publication type:
- Article